Skip to content

Clinical trials

Observational Heart Failure trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Observational Country / region: United States Clear all

512 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20024
20035
200410
200517
200618
200729
200818
200919
201016
201119
201226
201314
201427
201525
201619
201724
201826
201916
202029
202127
202228
202324
202420
202522
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed297
Recruiting71
Terminated48
Unknown status34
Withdrawn22
Active, not recruiting20
Enrolling by invitation16
Not yet recruiting3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices23
Medtronic Cardiac Rhythm and Heart Failure18
Mayo Clinic15
Medtronic14
National Heart, Lung, and Blood Institute (NHLBI)13
Boston Scientific Corporation12
Brigham and Women's Hospital11
The Cleveland Clinic11
Massachusetts General Hospital8
Northwestern University8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure512
Cardiomyopathies35
Arrhythmias, Cardiac26
Cardiovascular Diseases26
Hypertension23
Heart Diseases21
Atrial Fibrillation20
Diabetes Mellitus19
Pulmonary Disease, Chronic Obstructive19
Myocardial Infarction18

Trials

Showing 1 to 25 of 512. Each trial links to its page on Pharma Observatory.

412 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.